14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.70 $93.35 Wednesday, 24th Apr 2024 BMRN stock ended at $91.20. This is 0.93% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.20% from a day low at $91.01 to a day high of $93.02.
90 days $83.44 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Sep 22, 2021 $78.61 $79.63 $77.42 $79.03 1 061 928
Sep 21, 2021 $77.16 $78.87 $77.16 $78.15 1 177 222
Sep 20, 2021 $77.26 $78.69 $76.84 $77.38 1 060 620
Sep 17, 2021 $76.42 $77.98 $76.40 $77.76 3 064 336
Sep 16, 2021 $76.66 $77.30 $75.82 $76.50 795 384
Sep 15, 2021 $76.90 $77.44 $76.00 $77.27 1 238 494
Sep 14, 2021 $78.50 $78.69 $76.10 $76.17 791 027
Sep 13, 2021 $78.21 $78.78 $77.67 $77.98 1 372 442
Sep 10, 2021 $80.64 $81.17 $77.93 $77.98 1 318 564
Sep 09, 2021 $78.61 $80.58 $77.73 $80.11 2 130 231
Sep 08, 2021 $77.71 $78.27 $76.57 $76.70 1 522 864
Sep 07, 2021 $78.01 $81.92 $77.60 $77.81 2 484 399
Sep 03, 2021 $85.15 $85.24 $84.36 $84.95 1 031 298
Sep 02, 2021 $84.14 $85.24 $83.33 $85.15 994 193
Sep 01, 2021 $84.52 $85.28 $83.69 $84.27 840 040
Aug 31, 2021 $82.48 $84.50 $82.25 $84.21 1 478 224
Aug 30, 2021 $83.76 $85.01 $83.06 $83.27 1 598 992
Aug 27, 2021 $79.13 $84.23 $79.10 $83.51 2 127 065
Aug 26, 2021 $78.85 $79.41 $78.13 $78.82 1 004 339
Aug 25, 2021 $77.06 $78.67 $76.82 $78.52 922 169
Aug 24, 2021 $75.41 $77.29 $75.20 $77.24 1 239 919
Aug 23, 2021 $75.45 $75.70 $75.16 $75.47 880 587
Aug 20, 2021 $74.86 $75.54 $74.65 $75.14 1 238 735
Aug 19, 2021 $75.51 $76.74 $74.68 $74.77 1 155 865
Aug 18, 2021 $76.58 $76.67 $75.34 $75.54 726 320
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT